Warfarin use associates with increased risk for stroke in hemodialysis patients with atrial fibrillation.
about
Stroke prevention in the elderly atrial fibrillation patient with comorbid conditions: focus on non-vitamin K antagonist oral anticoagulantsStroke and Chronic Kidney Disease: Epidemiology, Pathogenesis, and Management Across Kidney Disease StagesPrognostic impact of atrial fibrillation on clinical outcomes of acute coronary syndromes, heart failure and chronic kidney diseaseOral anticoagulant therapy in patients receiving haemodialysis: is it time to abandon it?Sailing between Scylla and Charybdis: oral long-term anticoagulation in dialysis patientsSystematic review and meta-analysis of incidence, prevalence and outcomes of atrial fibrillation in patients on dialysisAnticoagulation for atrial fibrillation in patients on dialysis: are the benefits worth the risks?Evidence for the prevention and treatment of stroke in dialysis patientsStrategies for postmarketing surveillance of drugs and devices in patients with ESRD undergoing dialysisCost-Effectiveness of Cardiac Radiosurgery for Atrial Fibrillation: Implications for Reducing Health Care Morbidity, Utilization, and Costs.Anticoagulation Therapy in Patients with Chronic Kidney Disease.Correlates and variance decomposition analysis of heparin dosing for maintenance hemodialysis in older US patientsCardiovascular disease in CKD in 2012: moving forward, slowly but surely.Stroke in Patients with Chronic Kidney Diseaseā¦: How do we Approach and Manage it?Modeling the 4D Study: statins and cardiovascular outcomes in long-term hemodialysis patients with diabetesIntersection of cardiovascular disease and kidney disease: atrial fibrillation.Dephosphorylated-uncarboxylated Matrix Gla protein concentration is predictive of vitamin K status and is correlated with vascular calcification in a cohort of hemodialysis patients.Rapidly progressive severe vascular calcification sparing the kidney allograft following warfarin initiation.The debate on warfarin use in dialysis patients with atrial fibrillation: more fuel for the fire.Digoxin associates with mortality in ESRD.The increasing prevalence of atrial fibrillation among hemodialysis patients.Circulating nonphosphorylated carboxylated matrix gla protein predicts survival in ESRD.Heparin use in hemodialysis patients following gastrointestinal bleeding.Mineral Metabolism Markers Are Associated with Myocardial Infarction and Hemorrhagic Stroke but Not Ischemic Stroke in Hemodialysis Patients: A Longitudinal Study.Warfarin use in hemodialysis patients with atrial fibrillation: decisions based on uncertainty.Dabigatran and rivaroxaban use in atrial fibrillation patients on hemodialysis.Anticoagulation in chronic kidney disease patients-the practical aspects.Effectiveness and safety of warfarin initiation in older hemodialysis patients with incident atrial fibrillation.Comprehensive risk reduction in patients with atrial fibrillation: emerging diagnostic and therapeutic options--a report from the 3rd Atrial Fibrillation Competence NETwork/European Heart Rhythm Association consensus conference.Prevalence and Impact on Stroke in Patients Receiving Maintenance Hemodialysis versus Peritoneal Dialysis: A Prospective Observational Study.Prevalence of atrial fibrillation and warfarin use in older patients receiving hemodialysis.Warfarin in atrial fibrillation patients with moderate chronic kidney diseaseEfficacy and safety of warfarin in dialysis patients with atrial fibrillation: a systematic review and meta-analysis.Dealing with prognostic signature instability: a strategy illustrated for cardiovascular events in patients with end-stage renal diseaseOutcomes After Warfarin Initiation in a Cohort of Hemodialysis Patients With Newly Diagnosed Atrial Fibrillation.Warfarin use and stroke, bleeding and mortality risk in patients with end stage renal disease and atrial fibrillation: a systematic review and meta-analysis.Prevalence of Atrial Fibrillation and Antithrombotic Therapy in Hemodialysis Patients: Cross-Sectional Results of the Vienna InVestigation of AtriaL Fibrillation and Thromboembolism in Patients on HemoDIalysis (VIVALDI).A hemodialysis cohort study of protocol-based anticoagulation management.Primary prevention of atrial fibrillation with beta-blockers in patients with end-stage renal disease undergoing dialysisAnticoagulants and acute kidney injury: clinical and pathology considerations.
P2860
Q26781181-6B8F16F1-46A3-4820-BE29-F07790B3ED4FQ26782013-1513249A-8DCC-4EC8-9480-394A0C10AFECQ26801625-43000DBF-1468-43C9-99DD-E29030625C4EQ26827576-DBC125D5-0BA1-436E-9A49-3A7719A984E9Q27006930-394890AC-9CDF-4F52-879D-3C9610351A4EQ27009350-C8DF40FD-3EFE-41E3-A957-8A31BF4CAE85Q27010464-CBDDB545-0966-4B6F-8AC7-0E46F9261828Q27023274-FA9876FD-891A-492E-9F88-46EDB5D47D73Q27694667-BF7A80AD-4CFD-4C7E-A1CD-F59EA168DF9FQ28077393-2FDDF5CF-6BFC-4A21-8D24-7463D8FD82C4Q33435357-82172B15-8EA3-4427-83B3-A313251E5C30Q33617196-E0632740-27EF-448D-8410-D2B7CD0F30AAQ33682243-C9E22271-23FE-4197-85E2-1F971866E22CQ33697353-F7E2F0E1-0B3A-40F9-BBD6-EFB22E8B0E09Q33827363-E51E814D-F957-4DC1-A69A-5CAF3A0C0A14Q34040279-39A96C1D-48CF-4AA4-B884-7168E83D9E81Q34241519-BAF9E08D-396A-4626-99C6-9CDCD500086BQ34348892-8D4F4754-ABC9-4C7A-8346-ED022B09DDF9Q34403796-77C38C58-2FF1-40F4-BA0B-40EAF8A3E78DQ34455390-20574BCB-3791-4BCA-A86F-3C5C2B83DAFCQ34534916-2BFD22C6-CB63-49A1-9931-1EC17287F874Q34534951-503E9AD5-0EF5-4D36-B42E-C464AF96D74FQ34580144-8A8E3EF9-3AC9-422D-8432-12EFD868FE92Q34672695-F673134C-A686-488F-B96A-703784E2D6A0Q34938763-B776735E-10F3-4333-9EED-13A2AE838B64Q35187005-FF7D5D48-B007-434B-9409-A6196E5EBC71Q35232128-E571A0E4-EEEB-412A-9D85-8A7166BA0F77Q35499647-DD813A7F-02C0-49C7-83E7-B33E363E0B6BQ35609742-1B878EF8-6D26-454B-8D58-931CCFD41885Q35814600-76611A4E-534A-4AA5-8213-84D994CF445FQ35846455-B3BF534B-C7B5-401E-A0F9-750A8214B840Q35985876-0DC636C6-8015-495A-90C5-99378204C078Q36069462-99FC4768-3F33-4864-8415-DF65635BFB12Q36083333-54406A34-701D-4FA2-9300-328C6B3B6AC7Q36096144-69A5DB2C-6631-4F2E-8F25-B926EAC82A63Q36171135-2AFF6D18-C6EF-4B3F-A52C-AF11BDE04B5BQ36239524-3A498915-989F-4FAA-BCDC-7B57E63318A1Q36261765-FDEC9D34-8A1A-4057-BE09-0E34D87ECC4FQ36353636-72281CB2-4817-4701-A3DE-38AE1AE4C699Q36466324-F1B04FCE-8689-4DE5-A982-993644EABCE3
P2860
Warfarin use associates with increased risk for stroke in hemodialysis patients with atrial fibrillation.
description
article cientĆfic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo cientĆfico
@pt
bilimsel makale
@tr
scientific article published on 27 August 2009
@en
vedeckĆ½ ÄlĆ”nok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vÄdeckĆ½ ÄlĆ”nek
@cs
name
Warfarin use associates with i ...... ents with atrial fibrillation.
@en
Warfarin use associates with i ...... ents with atrial fibrillation.
@nl
type
label
Warfarin use associates with i ...... ents with atrial fibrillation.
@en
Warfarin use associates with i ...... ents with atrial fibrillation.
@nl
prefLabel
Warfarin use associates with i ...... ents with atrial fibrillation.
@en
Warfarin use associates with i ...... ents with atrial fibrillation.
@nl
P2093
P2860
P356
P1476
Warfarin use associates with i ...... ents with atrial fibrillation.
@en
P2093
J Michael Lazarus
Kevin E Chan
Ravi Thadhani
Raymond M Hakim
P2860
P304
P356
10.1681/ASN.2009030319
P577
2009-08-27T00:00:00Z